Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Dec 5;92(25):11470–11474. doi: 10.1073/pnas.92.25.11470

Enhanced somatic mutation rates induced in stem cells of mice by low chronic exposure to ethylnitrosourea.

P M Shaver-Walker 1, C Urlando 1, K S Tao 1, X B Zhang 1, J A Heddle 1
PMCID: PMC40423  PMID: 8524785

Abstract

We have found that the somatic mutation rate at the Dlb-1 locus increases exponentially during low daily exposure to ethylnitrosourea over 4 months. This effect, enhanced mutagenesis, was not observed at a lacI transgene in the same tissue, although the two loci respond very similarly to acute doses. Since both mutations are neutral, the mutant frequency was expected to increase linearly with time in response to a constant mutagenic exposure, as it did for lacI. Enhanced mutagenesis does not result from an overall sensitization of the animals, since mice that had first been treated with a low daily dose for 90 days and then challenged with a large acute dose were not sensitized to the acute dose. Nor was the increased mutant frequency due to selection, since animals that were treated for 90 days and then left untreated for up to 60 days showed little change from the 90-day frequency. The effect is substantial: about 8 times as many Dlb-1 mutants were induced between 90 and 120 days as in the first 30 days. This resulted in a reverse dose rate effect such that 90 mg/kg induced more mutants when delivered at 1 mg/kg per day than at 3 mg/kg per day. We postulate that enhanced mutagenesis arises from increased stem cell proliferation and the preferential repair of transcribed genes. Enhanced mutagenesis may be important for risk evaluation, as the results show that chronic exposures can be more mutagenic than acute ones and raise the possibility of synergism between chemicals at low doses.

Full text

PDF
11470

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Gold L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990 Aug 31;249(4972):970–971. doi: 10.1126/science.2136249. [DOI] [PubMed] [Google Scholar]
  2. Bohr V. A., Smith C. A., Okumoto D. S., Hanawalt P. C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell. 1985 Feb;40(2):359–369. doi: 10.1016/0092-8674(85)90150-3. [DOI] [PubMed] [Google Scholar]
  3. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981 Jun;66(6):1191–1308. [PubMed] [Google Scholar]
  4. Fishel R., Lescoe M. K., Rao M. R., Copeland N. G., Jenkins N. A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993 Dec 3;75(5):1027–1038. doi: 10.1016/0092-8674(93)90546-3. [DOI] [PubMed] [Google Scholar]
  5. Grosovsky A. J., Little J. B. Evidence for linear response for the induction of mutations in human cells by x-ray exposures below 10 rads. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2092–2095. doi: 10.1073/pnas.82.7.2092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hanawalt P. C. Transcription-coupled repair and human disease. Science. 1994 Dec 23;266(5193):1957–1958. doi: 10.1126/science.7801121. [DOI] [PubMed] [Google Scholar]
  7. Kohler S. W., Provost G. S., Fieck A., Kretz P. L., Bullock W. O., Putman D. L., Sorge J. A., Short J. M. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ Mol Mutagen. 1991;18(4):316–321. doi: 10.1002/em.2850180421. [DOI] [PubMed] [Google Scholar]
  8. Kohler S. W., Provost G. S., Fieck A., Kretz P. L., Bullock W. O., Sorge J. A., Putman D. L., Short J. M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7958–7962. doi: 10.1073/pnas.88.18.7958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kohler S. W., Provost G. S., Kretz P. L., Dycaico M. J., Sorge J. A., Short J. M. Development of a short-term, in vivo mutagenesis assay: the effects of methylation on the recovery of a lambda phage shuttle vector from transgenic mice. Nucleic Acids Res. 1990 May 25;18(10):3007–3013. doi: 10.1093/nar/18.10.3007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lee A. T., DeSimone C., Cerami A., Bucala R. Comparative analysis of DNA mutations in lacI transgenic mice with age. FASEB J. 1994 May;8(8):545–550. doi: 10.1096/fasebj.8.8.8181674. [DOI] [PubMed] [Google Scholar]
  11. Loeb L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991 Jun 15;51(12):3075–3079. [PubMed] [Google Scholar]
  12. McGregor W. G., Chen R. H., Lukash L., Maher V. M., McCormick J. J. Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair-deficient cells. Mol Cell Biol. 1991 Apr;11(4):1927–1934. doi: 10.1128/mcb.11.4.1927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nowell P. C. Foundations in cancer research. Chromosomes and cancer: the evolution of an idea. Adv Cancer Res. 1993;62:1–17. doi: 10.1016/s0065-230x(08)60313-9. [DOI] [PubMed] [Google Scholar]
  14. Potten C. S., Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 1990 Dec;110(4):1001–1020. doi: 10.1242/dev.110.4.1001. [DOI] [PubMed] [Google Scholar]
  15. Shephard S. E., Lutz W. K., Schlatter C. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo. Mutat Res. 1994 Apr 15;306(2):119–128. doi: 10.1016/0027-5107(94)90022-1. [DOI] [PubMed] [Google Scholar]
  16. Skopek T. R., Kort K. L., Marino D. R. Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice. Environ Mol Mutagen. 1995;26(1):9–15. doi: 10.1002/em.2850260103. [DOI] [PubMed] [Google Scholar]
  17. Tao K. S., Heddle J. A. The accumulation and persistence of somatic mutations in vivo. Mutagenesis. 1994 May;9(3):187–191. doi: 10.1093/mutage/9.3.187. [DOI] [PubMed] [Google Scholar]
  18. Tao K. S., Urlando C., Heddle J. A. Comparison of somatic mutation in a transgenic versus host locus. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10681–10685. doi: 10.1073/pnas.90.22.10681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tao K. S., Urlando C., Heddle J. A. Mutagenicity of methyl methanesulfonate (MMS) in vivo at the Dlb-1 native locus and a lacI transgene. Environ Mol Mutagen. 1993;22(4):293–296. doi: 10.1002/em.2850220419. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES